WHO ICTRP trial
A randomized, controlled study on treatment of membranous nephropathy by Wenyang…
ChiCTR2300067939 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300067939 |
|---|---|
| Public title | A randomized, controlled study on treatment of membranous nephropathy by Wenyang Jiebiao Regimen |
| Scientific title | A randomized, controlled study on treatment of membranous nephropathy by Wenyang Jiebiao Regimen - A randomized, controlled study on treatment of membranous nephropathy by Wenyang Jiebiao Regimen |
| Primary sponsor | Beijing Hospital of TCM, Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 2-3 |
| Countries | China |
| Conditions | Membranous Nephropathy |
| Interventions | MFSD Group:MAFU Granules + basic treatment;CsA Group:cyclosporine + basic treatment |
| Registration date | Feb 1, 2023 |
| Target size | MFSD Group:30;CsA Group:30 |
| Secondary IDs | ChiMCTR2300006966 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: